Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × EGFR Mutant Advanced Non Small Cell Lung Cancer × tremelimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mesothelioma, Malignant 3 Melanoma 2 Squamous Cell Carcinoma of Head and Neck 1 Platinum-resistant Recurrent Ovarian Cancer 1 Lung Neoplasms 1 Laryngeal Diseases 1 Kidney Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 EGFR Mutant Advanced Non Small Cell Lung Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma Of Esophagus 1

Interventions

tremelimumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03994393 2023-04-21

ILLUMINATE

University of Sydney

Phase 2 Unknown

EGFR Mutant Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡